-
Study aim
-
Evaluating the efficacy and safety of two methods of intra-articular injection and 4 injections at the joint level in the recovery of sacroiliac joint pain
-
Design
-
Clinical trial with two intervention groups, with parallel groups, double-blind, phase 2 on 40 patients, randomized
-
Settings and conduct
-
The place of study is the office of the supervisors and consultants (pain fellowship and endocrinology specialist), in the first group (20 people) intra-articular injection and in the second group (20 people) peri-articular injection (4 specific points around the joint) by a specialist doctor. will be The injected drug is the same in both groups. double blind (patient and researcher). Pain level of patients according to VAS scale (before injection, one hour after injection, one month after injection). Also, side effects are determined after the intervention.
-
Participants/Inclusion and exclusion criteria
-
Admission requirements: patients (ASA (American Society of Anesthesiologists) in class I and II, 18 years old and above, referred to the Yazd city pain clinic, who came with complaints of back pain and during clinical examinations, they had a clinical diagnosis of SIJ joint pain.
Exclusion conditions: history of any uncontrolled medical disease - history of rheumatological or infectious diseases (RA, brucellosis)
-
Intervention groups
-
First group: intra-articular injection
The second group: injection around the joint (4 specific points around the joint)
The drug injected in both groups is the same, which includes a mixture of Hexal brand triamcinolone in the amount of 40 mg plus Myungmoon brand marcaine (bupivacaine) in the amount of 0-25% with a volume of 8cc, and the injection in both groups during the operation and the injection under guidance. Radiology (C-arm) will be performed by a specialist doctor.
-
Main outcome variables
-
pain intensity based on the VAS scale and side effects